Evidence map›Paper›PMID 26612138›Full record

ArticleScientific reports2015

A novel algorithm for analyzing drug-drug interactions from MEDLINE literature.

Yin Lu, Dan Shen, Maxwell Pietsch, Chetan Nagar, Zayd Fadli, Hong Huang, Yi-Cheng Tu, Feng Cheng

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Patents on PARP-1 Inhibitors for the Management of Cancer from 2017-2023.Recent patents on anti-cancer drug discovery · 2025
    Review
  3. Article
  4. TP-DDI: A Two-Pathway Deep Neural Network for Drug-Drug Interaction Prediction.Interdisciplinary sciences, computational life sciences · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yin LuDepartment of Pharmaceutical Science, College of Pharmacy, University of South Florida, Tampa, FL, 33612, USA.
Dan ShenDepartment of Mathematics &Statistics, University of South Florida, Tampa, FL, 33612, USA.
Maxwell PietschDepartment of Computer Science and Engineering, University of South Florida, Tampa, FL, 33612, USA.
Chetan NagarDepartment of Pharmaceutical Science, College of Pharmacy, University of South Florida, Tampa, FL, 33612, USA.
Zayd FadliCollege of Medicine, Syrian private university, Damascus, 0100, Syria.
Hong HuangSchool of Information, University of South Florida, Tampa, FL, 33612, USA.
Yi-Cheng TuDepartment of Computer Science and Engineering, University of South Florida, Tampa, FL, 33612, USA.
Feng ChengDepartment of Pharmaceutical Science, College of Pharmacy, University of South Florida, Tampa, FL, 33612, USA.

Funding

Database-centric data analysis of molecular simulationsR01GM086707 · NIGMS · UNIVERSITY OF SOUTH FLORIDA · PI TU, YICHENG · 2010 to 2014
$863k
NIGMS NIH HHS R01 GM086707NIGMS NIH HHS R01GM086707
6 · The paper itself

Abstract

Drug-drug interaction (DDI) is becoming a serious clinical safety issue as the use of multiple medications becomes more common. Searching the MEDLINE database for journal articles related to DDI produces over 330,000 results. It is impossible to read and summarize these references manually. As the volume of biomedical reference in the MEDLINE database continues to expand at a rapid pace, automatic identification of DDIs from literature is becoming increasingly important. In this article, we present a random-sampling-based statistical algorithm to identify possible DDIs and the underlying mechanism from the substances field of MEDLINE records. The substances terms are essentially carriers of compound (including protein) information in a MEDLINE record. Four case studies on warfarin, ibuprofen, furosemide and sertraline implied that our method was able to rank possible DDIs with high accuracy (90.0% for warfarin, 83.3% for ibuprofen, 70.0% for furosemide and 100% for sertraline in the top 10% of a list of compounds ranked by p-value). A social network analysis of substance terms was also performed to construct networks between proteins and drug pairs to elucidate how the two drugs could interact.

Indexed as

AlgorithmsContraindicationsDrug InteractionsEnzymesFurosemideHumansHydrolysisIbuprofenMEDLINESertralineWarfarinEnzymesFurosemideIbuprofenSertralineWarfarin

Identifiers

PMID26612138
PMCPMC4661569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.